Article Text

Download PDFPDF
Increasing incidence of asbestosis worldwide, 1990–2017: results from the Global Burden of Disease study 2017
  1. Meng Yang1,2,
  2. Dongming Wang1,2,
  3. Shiming Gan1,2,
  4. Lieyang Fan1,2,
  5. Man Cheng1,2,
  6. Linling Yu1,2,
  7. Bin Wang1,2,
  8. Wei Li1,2,
  9. Jixuan Ma1,2,
  10. Min Zhou1,2,
  11. Weihong Chen1,2
  1. 1 Department of Occupational and Environmental Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
  2. 2 Key Laboratory of Environment and Health, Ministry of Education & Ministry of Environmental Protection, and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
  1. Correspondence to Professor Weihong Chen, Department of Occupational and Environmental Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; wchen{at}mails.tjmu.edu.cn

Abstract

Global incidence and temporal trends of asbestosis are rarely explored. Using the detailed information on asbestosis from the Global Burden of Disease (GBD) 2017, we described the age-standardised incidence rate (ASIR) and its average annual percentage change. A Joinpoint Regression model was applied to identify varying temporal trends over time. Although the use of asbestos has been completely banned in many countries, the ASIR of asbestosis increased globally from 1990 to 2017. Furthermore, the most pronounced increases in ASIR of asbestosis were detected in high-income North America and Australasia. These findings indicate that efforts to change the asbestos regulation policy are urgently needed.

  • occupational Lung disease
  • asbestos-induced lung disease

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • MY and DW contributed equally.

  • Contributors MY, DW and WC designed the study; MY, SG, LF, MC and LY collected the data; MY performed statistical analysis; MY drafted the manuscript; WC, DW, BW, WL, MZ and JM revised the manuscript; WC had primary responsibility for final content. All authors conducted the interpretation of the result and read and approved the final manuscript.

  • Funding This study was supported by grants of the National Natural Science Foundation of China (81872593 and 81903291).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.